Turning Point Brands, Inc. (TPB) Company Overview

US | Consumer Defensive | Tobacco | NYSE

What does Turning Point Brands do?

NYSE: TPB
Common stock listing and ticker
2 segments
Zig-Zag Products and Stoker’s Products
220,000
Approximate North American retail outlets, FY2025
90%+
Share of FY2025 net sales generated in the United States

Turning Point Brands, Inc. is a Louisville-based manufacturer, marketer and distributor of branded products for adult consumers. Its continuing operations are concentrated in alternative smoking accessories and other tobacco products, with a growing emphasis on tobacco-free modern oral nicotine. The company’s official corporate profile describes a portfolio led by Zig-Zag, Stoker’s, FRE and ALP, sold through broad wholesale, convenience-store, specialty-retail and e-commerce channels.

Which brands and customers define the company?

Zig-Zag Products
Rolling papers, tubes, cones, make-your-own cigar wraps, finished cigars, lighters and accessories, plus Canadian distribution activities.
Stoker’s Products
Moist snuff, loose-leaf chewing tobacco and modern oral nicotine products, especially FRE and the ALP joint venture.
Route to market
More than 900 direct wholesalers and about 600 secondary U.S. wholesalers served the retail network in FY2025.

The business is primarily wholesale-led rather than direct-to-consumer. Distributors resell TPB products to convenience stores, tobacco outlets, food stores, mass merchants, drug stores, headshops and dispensaries. The company had no customer representing 10% or more of FY2025 net sales, reducing single-account concentration. Its official business overview also emphasizes the long heritage of Zig-Zag and the extension of established brands into adjacent formats.

Branded consumer productsWholesale distributionAdult nicotine categoriesAsset-light sourcingU.S.-weighted revenue

How does Turning Point Brands make money?

TPB earns revenue by selling physical products to wholesalers and retailers. Reported net sales include federal excise taxes and are recorded after cash discounts, returns, consumer promotions and trade allowances. Unlike a subscription company, TPB must repeatedly win shelf space, distributor orders and adult-consumer purchases. Its economics therefore depend on brand recognition, retail availability, product mix, pricing, trade promotion and disciplined inventory management.

What is the operating model from supplier to cash flow?

01
Source or manufacture
Most production is outsourced; in-house manufacturing is concentrated in Stoker’s moist snuff.
02
Build branded assortments
TPB packages established brands and develops formats such as cones, wraps and nicotine pouches.
03
Sell through distribution
Wholesalers and retail chains provide broad placement across traditional and specialty channels.
04
Fund growth from legacy cash
Cash-generative Zig-Zag and traditional Stoker’s products support modern oral marketing and capacity.
Zig-Zag papers and wraps
Demand logic: premium brand, frequent replenishment and wide retail distribution. Economics: strong segment operating margin, with sensitivity to product mix and tariffs. Constraint: licensed supply arrangements and shifting smoking-accessory demand.
Traditional Stoker’s
Demand logic: value positioning, tubs and cans, and repeat adult-consumer usage. Economics: established manufacturing and brand profitability. Constraint: category volume pressure, regulation and excise taxes.
Modern oral nicotine
Demand logic: FRE and ALP pouches sold through expanding retail distribution. Economics: rapid gross-profit growth offset by sales, freight and trade spending. Constraint: competition, regulatory authorization and the cost of acquiring share.

Which segment matters most to revenue and profit?

Q1 2026 net sales mix
Stoker’s Products — $87.6M — 70.5%
Zig-Zag Products — $36.7M — 29.5%
Stoker’s became the clear revenue engine in the quarter ended March 31, 2026, mainly because modern oral net sales reached $52.0M.

How did the full-year mix change?

FY2025 segment net sales
Stoker’s — $284.6M — 61.5%
Zig-Zag — $178.5M — 38.5%
Period: FY2025. Stoker’s net sales grew 69.1%, while Zig-Zag declined 7.2%.
Segment FY2025 net sales FY2025 gross profit Gross margin Segment operating income
Stoker’s Products $284.6M $168.4M 59.2% $109.1M
Zig-Zag Products $178.5M $95.9M 53.7% $58.9M
Consolidated $463.1M $264.3M 57.1% $95.3M after $72.7M unallocated corporate costs

The FY2025 Form 10-K shows that Stoker’s produced both more revenue and more gross profit than Zig-Zag. Yet the most important interpretation is not simply that one segment is larger. Stoker’s now combines mature smokeless-tobacco cash flows with the company’s highest-growth platform, while Zig-Zag remains a valuable brand and distribution asset whose U.S. papers and wraps shipments weakened.

42%Modern oral represented approximately 42% of Q1 2026 company net sales, up from 21% in Q1 2025.

What does the latest quarter show?

The quarter ended March 31, 2026 confirms both the opportunity and the cost of TPB’s strategic pivot. Consolidated sales increased, but operating income, net income, adjusted EBITDA and operating cash flow moved in the opposite direction because the company accelerated brand-building, distribution support, freight and trade spending behind modern oral products.

$124.3M
Q1 2026 net sales, up 16.8% year over year
$68.3M
Q1 2026 gross profit, up 14.6%
$12.5M
Q1 2026 operating income, down 46.2%
$11.7M
Q1 2026 net income attributable to TPB
$0.60
Q1 2026 diluted EPS versus $0.79 in Q1 2025
$25.9M
Q1 2026 adjusted EBITDA, down 6.5%

Why did margins fall while revenue rose?

41.8%
Modern oral share of Q1 2026 net sales, calculated from $52.0M of modern oral sales divided by $124.3M of consolidated net sales.
Q1 metric Q1 2026 Q1 2025 Interpretation
Gross margin 55.0% 56.0% Modern oral contributed growth but diluted consolidated margin mix.
Operating margin 10.0% 21.8% SG&A increased 53.2% to $55.8M, reflecting investment and freight costs.
Operating cash flow $(22.3)M $17.4M Inventory, other current assets and payment timing consumed cash.
Capital expenditures $5.1M $2.2M Capacity and operational investment increased with the growth program.

The detailed Q1 2026 Form 10-Q shows inventory rising to $129.6M from $108.0M at year-end and cash falling to $192.4M from $222.8M. The company’s Q1 earnings release raised full-year modern oral net-sales guidance to $210M-$225M but introduced adjusted EBITDA guidance of $70M-$90M, explicitly including the planned investment in sales, marketing and trade promotions.

The central Q1 2026 signal is not weak demand; it is a deliberate exchange of near-term margin and cash flow for faster modern oral distribution and brand scale.

What turning points still shape Turning Point Brands today?

TPB’s current strategy is best understood as repeated brand extension: use recognized names and an established wholesale network to enter adjacent categories. The official company timeline and filings connect several historical decisions directly to the present portfolio.

  1. 1879
    Zig-Zag’s heritage established the recognition that still supports premium rolling papers, cones and adjacent accessories.
  2. 1992
    Long-term U.S. and Canadian Zig-Zag distribution agreements created durable access to licensed paper products, but also supplier and contract dependence.
  3. 2009
    The Zig-Zag brand entered make-your-own cigar wraps and rapidly became a category leader, proving the brand-extension playbook.
  4. 2015
    Stoker’s moist snuff expanded from differentiated tubs into 1.2-ounce cans, increasing convenience-store distribution.
  5. 2019–2021
    TPB built a 65% stake in its Canadian distribution business and acquired Unitabac assets, widening geography and cigarillo options.
  6. 2023–2024
    FRE received a national rollout and TPB formed the ALP joint venture, placing modern oral at the center of growth strategy.
  7. 2025
    The former Creative Distribution Solutions business was contributed to GWO for a 49% equity interest, leaving two reportable segments and sharpening management focus.

What did the strategic reset change?

The 2025 portfolio simplification removed a lower-quality distribution business from continuing operations and made TPB easier to analyze: two branded segments, one legacy-heavy and one increasingly modern-oral-driven. It also left TPB with an equity-method investment and non-controlling interests that can complicate the bridge from consolidated net income to income attributable to common shareholders. More importantly, management reallocated people and promotional dollars away from weaker Zig-Zag categories and toward white nicotine pouches.

What gives Turning Point Brands a competitive advantage?

Brand leadership and shelf access

The strongest moat elements are not patents or network effects; they are brand memory, wholesale relationships, store-level data and the ability to extend brands into adjacent formats. In the 52 weeks ended December 27, 2025, Zig-Zag held 32.7% of measured cigarette papers and 34.3% of make-your-own cigar wraps. Stoker’s held 34.1% of chewing tobacco, while the broader company was the leading chewing-tobacco marketer with about 38.0% share.

Selected measured U.S. category shares — 52 weeks ended December 27, 2025
TPB chewing tobacco portfolio38.0%
Zig-Zag MYO cigar wraps34.3%
Stoker’s chewing tobacco34.1%
Zig-Zag cigarette papers32.7%
Stoker’s moist snuff8.1%
These are company-reported MSAi shares for measured channels, not total-market estimates for every retail outlet.

How durable is the moat?

Brand recognitionStrong
Retail distributionStrong
Cost advantageModerate
Regulatory insulationLimited
Supplier independenceLimited

The moat is real but bounded. TPB’s salesforce can use weekly shipment data from roughly 600 wholesalers covering more than 265,000 traditional U.S. retail stores, helping prioritize high-opportunity outlets. However, several larger tobacco companies have much greater capital, promotional budgets and retailer leverage. TPB also licenses important Zig-Zag intellectual property and relies on third-party suppliers, so brand strength does not eliminate contract and sourcing risk.

Who are Turning Point Brands’ main competitors?

Competition varies by category. In rolling papers, TPB faces Republic Tobacco and HBI International. In wraps, it competes with Good Times USA and New Image Global. In traditional smokeless products and modern oral nicotine, it faces Swedish Match, American Snuff, Swisher, U.S. Smokeless Tobacco, Modoral and Helix—many backed by Philip Morris International, British American Tobacco or Altria.

Premium rolling papers
Rivals: Republic Tobacco and HBI International. TPB position: Zig-Zag ranked first overall and in premium measured U.S. channels. Competition centers on brand, price, innovation and shelf visibility.
Make-your-own cigar wraps
Rivals: Good Times USA and New Image Global. TPB position: Zig-Zag ranked first overall. Pressure comes from flavor and format competition, regulation and substitution with papers or finished cigars.
Traditional smokeless
Rivals: Swedish Match, American Snuff, Swisher and U.S. Smokeless Tobacco. TPB position: discount strength and chewing-tobacco leadership. Pricing, loyalty, placement and category decline determine outcomes.
Modern oral nicotine
Rivals: Swedish Match, Modoral, Swisher and Helix. TPB position: fast-growing challenger through FRE and ALP. Scale, trade spend, consumer acquisition, authorization and distribution speed are decisive.

How financially strong is Turning Point Brands?

FY2025 earnings base
$119.5M adjusted EBITDA
Up 14.4% from FY2024, despite rising corporate investment.
Q1 2026 liquidity
$265.0M
$192.4M cash plus $72.6M available under the asset-backed revolver.
Q1 2026 net debt
$101.4M
Manageable against liquidity, but debt carries a 7.625% coupon.

Profitability, cash flow and working capital

FY2025 was financially strong: revenue rose 28.4% to $463.1M, operating income increased 17.9% to $95.3M and net income attributable to TPB reached $58.2M. The resulting operating margin was about 20.6%. Operating cash flow from continuing operations was $57.4M, and subtracting $13.5M of capital expenditures produces approximately $43.8M of simple free cash flow. This supports the description of the model as asset-light, although capex nearly tripled from FY2024 as modern oral investment accelerated.

Financial-health item Period and value Research implication
Cash $192.4M at March 31, 2026 Provides room to fund inventory, promotion and capacity despite negative Q1 operating cash flow.
Long-term debt $293.9M at March 31, 2026 Primarily 7.625% senior secured notes due 2032; higher interest cost raises the hurdle for reinvestment.
Inventory $129.6M at March 31, 2026 Up $21.6M from year-end; growth must convert into sell-through rather than slow-moving stock.
Adjusted working capital $154.5M at March 31, 2026 Up from $119.4M at year-end, reflecting the operating build required for expansion.
Q1 simple free cash flow Approximately $(27.4)M Calculated as $(22.3)M operating cash flow less $5.1M capex; a key near-term pressure point.

How is capital being allocated?

Use of capital Current evidence What it signals
Modern oral growth FY2026 adjusted EBITDA guidance of $70M-$90M includes sales, marketing and trade investment Management is prioritizing category share over near-term margin.
Dividend $0.08 per share quarterly dividend paid in April 2026 A modest recurring return, constrained by debt-covenant conditions.
Repurchases $200M authorization; no repurchases in Q1 2026 Optionality exists, but current cash is being preserved for operations and growth.
Debt refinancing $300M of 7.625% notes due 2032 issued in February 2025 Maturity risk was extended, but annual interest expense increased.

The FY2025 results release provides the annual earnings baseline, while the 2026 dividend decisions show that shareholder distributions remain secondary to preserving strategic flexibility.

Who owns Turning Point Brands stock, and how is it governed?

19.34M
Shares outstanding on the March 12, 2026 record date
1 vote
Per outstanding common share
7 of 10
2026 director nominees identified as independent
5.4%
Directors and executive officers as a group

Economic ownership and influence

Holder or group Beneficial ownership Source period Why it matters
The Vanguard Group 1,404,963 shares; 7.3% 2026 proxy disclosure Large passive ownership increases institutional governance influence.
BlackRock 1,358,204 shares; 7.0% 2026 proxy disclosure Another significant institutional vote in a one-share-one-vote structure.
Directors and executive officers 1,052,402 shares; 5.4% March 12, 2026 Meaningful alignment, but not enough for insider control.
Graham A. Purdy, CEO 227,914 shares; 1.2% March 12, 2026 CEO incentives are directly exposed to the success of the growth pivot.
David E. Glazek, Executive Chairman 253,299 shares; 1.3% March 12, 2026 Executive-chair structure gives the board leadership an active strategic role.

The 2026 proxy statement indicates dispersed ownership rather than founder or family control. Seven of ten nominees were classified as independent, and the board operates audit, compensation, and nominating and governance committees composed as required by NYSE rules. CEO Graham Purdy has been with TPB since 2004 and became chief executive in 2022; that operating continuity matters because the present strategy relies on execution across brands, manufacturing, distributors and regulation rather than a single product launch.

What opportunities and risks could change the story?

High impact / Near term
Modern oral distribution and repeat purchase. Q1 2026 sales already reached $52.0M, making execution the primary earnings swing factor.
High impact / Longer term
Regulatory authorization and category structure. Durable legal market access can determine whether current brand investment earns attractive returns.
Moderate impact / Near term
Zig-Zag U.S. shipment stabilization, tariffs, freight and inventory conversion can improve or pressure quarterly margins and cash flow.
Moderate impact / Longer term
Canadian expansion, e-commerce, adjacent formats and disciplined acquisitions can widen the portfolio without changing the core model.

Where is the upside?

  • Modern oral scale: FY2026 net-sales guidance of $210M-$225M implies the category can become TPB’s largest product platform.
  • Distribution leverage: Existing wholesaler and retail relationships can reduce the time needed to place new FRE and ALP SKUs.
  • Legacy funding: Zig-Zag and traditional Stoker’s products can finance growth if their cash generation remains resilient.
  • Mix recovery: Better pouch manufacturing economics and lower launch spending could restore operating leverage after the investment phase.

Which risks are most material?

Risk Financial transmission Evidence to monitor
FDA and state regulation Products can face authorization, registry, labeling, marketing or distribution restrictions. PMTA status, state registries, enforcement priorities and compliance expense.
Large tobacco competitors Higher trade spend or pricing pressure can reduce pouch economics and slow share gains. Modern oral growth versus SG&A, trade allowances and adjusted EBITDA.
Supplier and license dependence Disruption with RTI, Swedish Match or contract manufacturers could affect supply and brand access. Inventory buffers, contract renewals, service levels and product availability.
Working-capital build Inventory and promotion can consume cash before retail sell-through is proven. Inventory days, operating cash flow and accounts-payable timing.
Taxes, tariffs and consumer shifts Cost inflation or higher retail prices can compress margins and volumes. Zig-Zag gross margin, U.S. papers shipments and excise-tax developments.
Leverage and covenant limits 7.625% secured debt raises fixed charges and can limit dividends or repurchases. Net debt, interest coverage, revolver availability and covenant compliance.

The company’s regulatory exposure is not peripheral; it is embedded in product-market access. The official regulatory affairs materials and risk factors should be read alongside financial results because authorization, excise tax and state registry rules can alter both revenue and cost structure.

Which KPIs matter most for valuation and future monitoring?

A DCF for TPB should not extrapolate consolidated revenue without separating legacy categories from modern oral. The growth business requires more selling expense, trade promotion, inventory and capacity, so its near-term revenue contribution is not equivalent to mature Zig-Zag or Stoker’s revenue. Analysts should model the transition through explicit assumptions for category growth, market share, gross margin, SG&A intensity and working-capital normalization.

Modern oral net sales
Track progress against FY2026 guidance of $210M-$225M and the quarterly growth rate beyond launch comparisons.
Modern oral share of company sales
At 41.8% in Q1 2026, it now changes the consolidated margin and risk profile.
Gross margin by segment
Watch whether Stoker’s margin stabilizes after mix dilution and whether Zig-Zag tariffs ease.
SG&A as a percentage of sales
Q1 spending rose faster than revenue; future operating leverage depends on this ratio declining.
Operating cash flow and inventory
The Q1 cash outflow is acceptable only if working capital supports profitable sell-through.
Zig-Zag U.S. shipment trend
Stabilization would protect the legacy cash engine while management funds pouches.
Net debt and interest expense
Debt is manageable today, but the 7.625% coupon makes sustained cash conversion important.
Regulatory milestones
PMTA decisions and state rules can change terminal growth and the discount rate.

How should the DCF drivers be organized?

DCF driver Base analytical question Main sensitivity
Revenue growth Can modern oral growth more than offset legacy declines? Distribution, repeat purchase, competitive share and regulation
Gross margin Does scale improve pouch economics after trade and freight costs? Product mix, manufacturing, tariffs and pricing
Operating margin When does marketing intensity normalize? SG&A productivity and brand investment duration
Reinvestment How much inventory, capex and promotion are needed per dollar of growth? Working-capital turns and capacity utilization
Terminal risk How durable are legal market access, brand licenses and category demand? Regulatory outcomes, consumer behavior and supplier continuity
Key takeaway from Turning Point Brands analysis
Turning Point Brands matters because it is attempting to use durable but mature brands, an extensive wholesale network and legacy cash generation to build a much larger position in modern oral nicotine. FY2025 proved that this transition can accelerate revenue and gross profit; Q1 2026 proved that it can also depress operating margin and consume working capital. The strongest case rests on FRE and ALP achieving repeat demand and scale economics before competitors or regulation raise acquisition costs. The most important monitoring question is therefore not whether modern oral can grow—it already has—but whether that growth converts into sustainable operating profit and free cash flow without weakening the Zig-Zag and traditional Stoker’s funding base.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

(TPB) Turning Point Brands, Inc. Bundle

Get Full Bundle:
$17 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5